Adia Nutrition ADIA
OTC ADIA
$0.12 +0.00 (+0.00%)
At close: Sep 17, 2026 · 4:00 PM EDT

Adia Nutrition (ADIA) Operating Leases (2024 - 2026)

Adia Nutrition's (ADIA) quarterly Operating Leases came in at $82010.0 in Q2 2026, down 14.64% quarter-over-quarter from $96076.0 in Q1 2026.

Analysis

Adia Nutrition (ADIA) Operating Leases (2024 - 2026) Analysis & Trends

Adia Nutrition (ADIA) has reported Operating Leases for 3 consecutive years, with $82010.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Leases changed N/A year-over-year to $82010.0 in Q2 2026; TTM through Jun 2026 was $82010.0, a N/A change from a year earlier, with the FY2025 full-year figure at $109868.0, down 29.4% from the prior year.
  • Operating Leases was $82010.0 for Q2 2026 at Adia Nutrition, down from $96076.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $155624.0 in Q4 2024 and troughed at $82010.0 in Q2 2026.
  • A 3-year average of $110894.5 and a median of $102972.0 in 2025 frame the typical range for Operating Leases.
  • The widest YoY moves for Operating Leases: up 29.4% in 2025, down 29.4% in 2025.
  • Over 3 years, Operating Leases stood at $155624.0 in 2024, then declined by 29.4% to $109868.0 in 2025, then retreated by 25.36% to $82010.0 in 2026.
  • The last three Operating Leases figures came in at $82010.0 (Q2 2026), $96076.0 (Q1 2026), and $109868.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 9.96 Bn 9.12 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.47 Bn 5.47 Bn -
3 Iovance Biotherapeutics 4.64 Bn 4.35 Bn 55.72 Mn
4 Legend Biotech 3.25 Bn 2.28 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Precigen 2.79 Bn 2.79 Bn 52.17 Mn
7 Beam Therapeutics 2.58 Bn 2.58 Bn -
8 Sarepta Therapeutics 2.12 Bn 1.33 Bn 251.87 Mn
9 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
10 Adia Nutrition 11.33 Mn 11.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82,010.00
Mar 31, 2026 96,076.00
Dec 31, 2025 109,868.00
Dec 31, 2024 155,624.00